Trials / Terminated
TerminatedNCT01436032
Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of Intravenous N1539 in Subjects After Abdominal Laparoscopic Surgery
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Alkermes, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N1539 | IV |
| DRUG | N1539 | IV |
| DRUG | N1539 | IV |
| DRUG | Ketorolac Tromethamine | IV |
| DRUG | Placebo | IV |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-03-01
- Completion
- 2012-03-01
- First posted
- 2011-09-19
- Last updated
- 2012-03-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01436032. Inclusion in this directory is not an endorsement.